Cassandra Gauthier

Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.

Atsushi Mizukami, Jun Fujimoto, Koji Fuji, 2014, Bioorganic & medicinal chemistry.

Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.

Hideki Matsui, Shoji Fukumoto, Midori Ono, 2011, Journal of medicinal chemistry.

Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.

K. Lackey, R. Mook, A. Walker, 2006, Bioorganic & medicinal chemistry letters.

Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists.

Atsushi Mizukami, Hideki Matsui, Shoji Fukumoto, 2013, Bioorganic & medicinal chemistry.